Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10001753201
During the last several years, government spending on drugs used to treat schizophrenia and other psychotic illnesses has increased at more than 30% per year, with the $3 billion in 2001 Medicaid expenditures exceeding spending in any other therapeutic category. This growth has been primarily...
Persistent link: https://www.econbiz.de/10013232140
Persistent link: https://www.econbiz.de/10009266609
Persistent link: https://www.econbiz.de/10008732288
Persistent link: https://www.econbiz.de/10009562852
Persistent link: https://www.econbiz.de/10003336419
Persistent link: https://www.econbiz.de/10002469626
"On January 1, 2006, the federal government began providing insurance coverage for Medicare recipients' prescription drug expenditures through a new program known as Medicare Part D. Rather than setting pharmaceutical prices itself, the government contracted with private insurance plans to...
Persistent link: https://www.econbiz.de/10003687797
On January 1, 2006, the federal government began providing insurance coverage for Medicare recipients' prescription drug expenditures through a new program known as Medicare Part D. Rather than setting pharmaceutical prices itself, the government contracted with private insurance plans to...
Persistent link: https://www.econbiz.de/10012759410
During the last several years, government spending on drugs used to treat schizophrenia and other psychotic illnesses has increased at more than 30% per year, with the $3 billion in 2001 Medicaid expenditures exceeding spending in any other therapeutic category. This growth has been primarily...
Persistent link: https://www.econbiz.de/10012469072